Acute severe autoimmune hepatitis with anti-rods and rings autoantibodies; literature first evidence
- PMID: 33868616
- PMCID: PMC8035537
Acute severe autoimmune hepatitis with anti-rods and rings autoantibodies; literature first evidence
Abstract
Autoimmune hepatitis (AIH) was defined as a progressive, chronic inflammatory autoimmune liver disease (ALD). The diagnosis of AIH requires the presence of characteristic clinical and laboratory features, and the exclusion of other clinical conditions that cause chronic hepatitis and cirrhosis. AIH can have an acute onset that mimics an acute viral or toxic hepatitis or an acute severe (fulminant, ASF) presentation that satisfies criteria for acute liver. Guidelines from the European Association for the Study of Liver Diseases define ALF with absence of pre-existing liver disease, acute onset of ≤ 26 weeks, coagulopathy (international normalised ratio (INR) ≥ 1.5), and presence of hepatic encephalopathy (HE). In recent years, autoantibodies (Aab) targeting subcellular structures described as the rods and rings (R&R) pattern in HEp-2 ANA have been presented as a unique and particular case of Aab generation. These R&R structures are composed of inosine monophosphate dehydrogenase type 2 (IMPDH2), and their formation can be induced in vitro by several small-molecule inhibitors. Aab targeting these relatively unknown structures has been observed in Hepatitis C virus (HCV) patients who have undergone treatment with pegylated interferona/ ribavirin (IFN/RBV) therapy. We presented and characterized a case patient with R&R and SMA Aab in AIH (ASF, fatal, without liver transplantation). To the best of our knowledge, this is the first evidence described in the Literature. Our early experience showed the R&R circulating Aab in one patient with Primary Biliary Cholangitis. This work now demonstrates that R&R Aab can also be present in AIH case.
Keywords: Autoimmun hepatitis; Autoimmun liver disease; Rods and rings antibodies.
©2021 RIGLD, Research Institute for Gastroenterology and Liver Diseases.
Figures



Similar articles
-
Primary biliary cholangitis with contemporary presence of anti-mithocondrial and anti-rods and rings autoantibodies: literature first case.Gastroenterol Hepatol Bed Bench. 2019 Winter;12(1):76-82. Gastroenterol Hepatol Bed Bench. 2019. PMID: 30949324 Free PMC article.
-
Anti-rods/rings: a human model of drug-induced autoantibody generation.Front Immunol. 2015 Feb 5;6:41. doi: 10.3389/fimmu.2015.00041. eCollection 2015. Front Immunol. 2015. PMID: 25699057 Free PMC article. Review.
-
Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.World J Gastroenterol. 2016 Feb 14;22(6):1966-74. doi: 10.3748/wjg.v22.i6.1966. World J Gastroenterol. 2016. PMID: 26877604 Free PMC article. Review.
-
Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.Minerva Gastroenterol Dietol. 2009 Mar;55(1):53-70. Minerva Gastroenterol Dietol. 2009. PMID: 19212308 Review.
-
[Autoimmune hepatitis and overlap syndrome: diagnosis].Praxis (Bern 1994). 2002 Aug 21;91(34):1339-46. doi: 10.1024/0369-8394.91.34.1339. Praxis (Bern 1994). 2002. PMID: 12233264 Review. German.
Cited by
-
The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China.Front Immunol. 2022 Sep 27;13:1007257. doi: 10.3389/fimmu.2022.1007257. eCollection 2022. Front Immunol. 2022. PMID: 36238277 Free PMC article.
-
High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection.Eur J Med Res. 2022 Sep 16;27(1):180. doi: 10.1186/s40001-022-00809-6. Eur J Med Res. 2022. PMID: 36114565 Free PMC article.
References
-
- EASL Clinical Practice Guidelines. Autoimmune hepatitis. J Hepatol. 2021;63:971–1004. - PubMed
-
- Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. J Autoimmun. 2018;95:144–58. - PubMed
-
- EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81. - PubMed
-
- Calise SJ, Carcamo WC, Ceribelli A, Dominguez Y, Satoh M, Chan EK. Antibodies to rods and rings. In: Shoenfeld Y, Meroni PL, Gershwin ME, editors. New York: Elsevier Science; 2014. pp. 161–168.
-
- Carcamo WC, Ceribelli A, Calise SJ, Krueger C, Liu C, Daves M, et al. Differential reactivity to IMPDH2 by antirods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients. J Clin Immunol. 2013;33:420–6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources